Skip to main content
. Author manuscript; available in PMC: 2014 Apr 3.
Published in final edited form as: Am J Obstet Gynecol. 2012 Oct 24;208(1):48.e1–48.e8. doi: 10.1016/j.ajog.2012.10.876

Table 2.

Baseline demographic and behavioral characteristics of women with objective weight measurements at baseline and 12 months.

Characteristics Substudy Analysis Sample (n=281) Perceived Weight Gain (n=111) Perceived No Weight Change (n=100) Perceived Weight Loss (n=70) P
Age (y) .836
 <21 37 (13.2) 15 (13.5) 15 (15.0) 7 (10.0)
 21–25 110 (39.1) 45 (40.5) 39 (39.0) 26 (37.1)
 >25 134 (47.7) 51 (46.0) 46 (46.0) 37 (52.9)
Race* <.001
 Black 141 (50.2) 75 (67.6) 40 (40.0) 26 (37.2)
 White 128 (45.5) 35 (31.5) 53 (53.0) 40 (57.1)
 Other 12 (4.3) 1 (0.9) 7 (7.0) 4 (5.7)
Marital Status .413
 Single 156 (55.5) 64 (57.7) 57 (57.0) 35 (50.0)
 Living with partner 66 (23.5) 28 (25.2) 17 (17.0) 21 (30.0)
 Married 40 (14.2) 12 (10.8) 18 (18.0) 10 (14.3)
 Separated/Divorced/Widowed 19 (6.8) 7 (6.3) 8 (8.0) 4 (5.7)
Insurance* .011
 None 90 (32.0) 44 (39.6) 28 (28.0) 18 (25.7)
 Private 151 (53.7) 51 (46.0) 64 (64.0) 36 (51.4)
 Public 40 (14.2) 16 (14.4) 8 (8.0) 16 (22.9)
Education .266
 High school diploma/GED or less 65 (23.1) 30 (27.1) 19 (19.0) 16 (22.9)
 Some College 110 (39.2) 44 (39.6) 35 (35.0) 31 (44.3)
 College degree or graduate school 106 (37.7) 37 (33.3) 46 (46.0) 23 (32.9)
Trouble paying for basic expenses* .004
 No 176 (62.9) 56 (50.9) 70 (70.0) 50 (71.4)
 Yes 104 (37.1) 54 (49.1) 30 (30.0) 20 (28.6)
Receiving Public Assistance* .001
 No 180 (64.1) 60 (54.1) 78 (78.0) 42 (60.0)
 Yes 101 (35.9) 51 (45.9) 22 (22.0) 28 (40.0)
Parity * .018
 Nulliparous 129 (45.9) 46 (41.4) 57 (57.0) 26 (37.1)
 Parous 152 (54.1) 65 (58.6) 43 (43.0) 44 (62.9)
Baseline BMI by CDC Classifications (kg/m2)* .035
 Underweight (<18.5) 9 (3.2) 2 (1.8) 5 (5.0) 2 (2.9)
 Normal (18.5–24.9) 121 (43.0) 39 (35.2) 55 (55.0) 27 (38.6)
 Overweight (25–29.9) 64 (22.8) 28 (25.2) 19 (19.0) 17 (24.3)
 Obese (≥30) 87 (31.0) 42 (37.8) 21 (21.0) 24 (34.3)
Baseline Method* .004
 LNG IUS 99 (35.2) 38 (34.2) 29 (29.0) 32 (45.7)
 Copper-IUD 73 (26.0) 18 (16.2) 35 (35.0) 20 (28.6)
 Implant 78 (27.8) 37 (33.4) 26 (26.0) 15 (21.4)
 DMPA 31 (11.0) 18 (16.2) 10 (10.0) 3 (4.3)
General Health .598
 Excellent 77 (27.4) 34 (30.6) 25 (25.0) 18 (25.7)
 Very good 123 (43.8) 50 (45.1) 45 (45.0) 28 (40.0)
 Good 73 (26.0) 23 (20.7) 28 (28.0) 22 (31.4)
 Fair 7 (2.5) 4 (3.6) 1 (1.0) 2 (2.9)
 Poor 1 (0.3) 0 (0.0) 1 (1.0) 0 (0.0)
General Health at 12 months .381
 Excellent 67 (24.0) 21 (19.1) 28 (28.0) 18 (26.1)
 Very good 124 (44.4) 48 (43.6) 42 (42.0) 34 (49.3)
 Good 71 (25.5) 34 (30.9) 25 (25.0) 12 (17.4)
 Fair 16 (5.7) 7 (6.4) 4 (4.0) 5 (7.2)
 Poor 1 (0.4) 0 (0.0) 1 (1.0) 0 (0.0)
Objective Weight* <.001
 Gain 114 (40.6) 85 (76.6) 26 (26.0) 3 (4.3)
 No Change 99 (35.2) 21 (18.9) 56 (56.0) 22 (31.4)
 Loss 68 (24.2) 5 (4.5) 18 (18.0) 45 (64.3)
 Mean WT Change (lbs)* 2.2 ±12.2 10.3 ±9.9 1.5 ±8.1 −9.5 ±10.5 <.001
*

Significant at alpha level of .05

P-value calculated using one-way ANOVA

P-value calculated using Fisher Exact Test. All other p-values calculated using χ2 test.

Data are n (%) or mean ± standard deviation unless otherwise specified.

GED, general education development test; DMPA, Depo-medroxyprogesterone acetate; IUC, intrauterine contraceptive; LNG, levonorgestrel. BMI, Body Mass Index.

Some n-values do not sum to total number in column heading, which accounts for missing responses.